Alarming serum antiprotease levels in axial spondyloarthritis.
Ayhan KulZeynep TüzünMuhammet CelikPublished in: Archives of rheumatology (2024)
The levels of SLPI and elafin were found to be significantly elevated in patients with AxSpA, particularly in those with nr-AxSpA, compared to the control group. Therefore, SLPI and elafin can be used as therapeutic biomarkers for the diagnosis of AxSpA and nr-AxSpA. However, no relationship was found with disease activity.